Results 61 to 70 of about 21,660 (161)

Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors. [PDF]

open access: yes, 2019
Purpose:To evaluate the safety, recommended phase II dose (RP2D) and efficacy of pexidartinib, a colony stimulating factor receptor 1 (CSF-1R) inhibitor, in combination with weekly paclitaxel in patients with advanced solid tumors.
Coussens, Lisa M   +12 more
core  

McCune Albright Syndrome [PDF]

open access: yes, 2020
Jibbe, Atieh   +2 more
core   +2 more sources

Fosfaattiaineenvaihdunnan säätely ja häiriöt [PDF]

open access: yes, 2016
•La­bo­ra­to­riossa mi­tattu plasman fos­fori ku­vaa pääo­sin fos­faattia. Klii­ni­sessä työs­sä ter­mejä ”fos­fori” ja ”fos­faatti” käy­tetään usein syno­nyy­meinä. •Plasman fos­faatti hei­jastaa huo­nosti ko­ko ke­hon fosfaat­ti­va­ras­toja.
Koistinen, Heikki, Miettinen, Helena
core  

Severe Unexplained Hypophosphatemia [PDF]

open access: yesClinical Chemistry, 1992
James A Young   +2 more
openaire   +2 more sources

Prognostic Significance of Hypophosphatemia in Kidney Transplant Patients: A Systematic Review and Meta-Analysis. [PDF]

open access: yesJ Evid Based Med
Charoenngam N   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy